NewGenIvf Group Statistics
Total Valuation
NewGenIvf Group has a market cap or net worth of $594,645. The enterprise value is $2.25 million.
Important Dates
Earnings Date | n/a |
Ex-Dividend Date | n/a |
Share Statistics
NewGenIvf Group has 1.70 million shares outstanding. The number of shares has increased by 2,316.76% in one year.
Current Share Class | 1.70M |
Shares Outstanding | 1.70M |
Shares Change (YoY) | +2,316.76% |
Shares Change (QoQ) | +185.91% |
Owned by Insiders (%) | 15.62% |
Owned by Institutions (%) | 7.13% |
Float | 1.40M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | 0.02 |
Forward PS | n/a |
PB Ratio | -0.40 |
P/TBV Ratio | n/a |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Financial Ratio History Enterprise Valuation
EV / Earnings | n/a |
EV / Sales | 0.41 |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.17
Current Ratio | 1.17 |
Quick Ratio | 1.06 |
Debt / Equity | n/a |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | -1.49 |
Financial Efficiency
Return on equity (ROE) is -53.76% and return on invested capital (ROIC) is -27.47%.
Return on Equity (ROE) | -53.76% |
Return on Assets (ROA) | -17.99% |
Return on Invested Capital (ROIC) | -27.47% |
Return on Capital Employed (ROCE) | -135.35% |
Revenue Per Employee | $77,620 |
Profits Per Employee | -$7,495 |
Employee Count | 70 |
Asset Turnover | 1.35 |
Inventory Turnover | 34.83 |
Taxes
Income Tax | -486,706 |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -98.85% in the last 52 weeks. The beta is 0.17, so NewGenIvf Group's price volatility has been lower than the market average.
Beta (5Y) | 0.17 |
52-Week Price Change | -98.85% |
50-Day Moving Average | 1.11 |
200-Day Moving Average | 9.94 |
Relative Strength Index (RSI) | 29.11 |
Average Volume (20 Days) | 6,211,446 |
Short Selling Information
The latest short interest is 142,106, so 8.37% of the outstanding shares have been sold short.
Short Interest | 142,106 |
Short Previous Month | 189,420 |
Short % of Shares Out | 8.37% |
Short % of Float | 10.18% |
Short Ratio (days to cover) | 0.25 |
Income Statement
In the last 12 months, NewGenIvf Group had revenue of $5.43 million and -$524,643 in losses. Loss per share was -$1.47.
Revenue | 5.43M |
Gross Profit | 1.83M |
Operating Income | -1.16M |
Pretax Income | n/a |
Net Income | -524,643 |
EBITDA | -1.14M |
EBIT | -1.16M |
Loss Per Share | -$1.47 |
Full Income Statement Balance Sheet
The company has $1.53 million in cash and $3.18 million in debt, giving a net cash position of -$1.65 million or -$0.97 per share.
Cash & Cash Equivalents | 1.53M |
Total Debt | 3.18M |
Net Cash | -1.65M |
Net Cash Per Share | -$0.97 |
Equity (Book Value) | -1.48M |
Book Value Per Share | -0.92 |
Working Capital | 452,391 |
Full Balance Sheet Cash Flow
In the last 12 months, operating cash flow was -$8.26 million and capital expenditures -$53,045, giving a free cash flow of -$8.32 million.
Operating Cash Flow | -8.26M |
Capital Expenditures | -53,045 |
Free Cash Flow | -8.32M |
FCF Per Share | -$4.90 |
Full Cash Flow Statement Margins
Gross margin is 33.62%, with operating and profit margins of -21.36% and -9.66%.
Gross Margin | 33.62% |
Operating Margin | -21.36% |
Pretax Margin | -17.68% |
Profit Margin | -9.66% |
EBITDA Margin | -21.00% |
EBIT Margin | -21.36% |
FCF Margin | n/a |